Outlook on the Contract Development & Manufacturing Organization (CDMO) Global Market to 2024 - Increasing Global Healthcare Expenditure is Driving Growth


Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global CDMO market is estimated to reach US$241.3 billion in 2024, growing at a CAGR of 9.80% for the period spanning from 2020 to 2024. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market. However, growth of the industry will be challenged by stringent government regulations. A few notable trends include increasing demand for highly potent API manufacturing services, growing demand for quality by design services, growth in oncology segment, growing demand for process development CDMO services and lengthy and costly drug development process.

The global API drug market accounted for the highest share of the market and is expected to grow in future owing to growing number of biologics APIs in pipeline stage and growing adoption of multiple therapies. In terms of geographical areas, North America is the major contributor to the global CDMO market supported by growing collaborations and wide range of services provided by CDMOs. The Asia Pacific is the fastest-growing market for CDMOs owing to highly skilled workforce and low research and development cost advantage.

Scope of the report:

  • The report provides a comprehensive analysis of the global CDMO industry.
  • The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players are also presented in detail.

Key Target Audience:

  • Contract Manufacturing Organization
  • Pharmaceutical Companies
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Key Topics Covered:

1. Introduction
1. Introduction
1.2 CDMO Services
1.3 Advantages of CDMO

2. Impact of COVID-19
2.1 Rise in Clinical Trials

3. Global CDMO Market Analysis
3.1 Global CDMO Market by Value
3.2 Global CDMO Market Forecast by Value
3.3 Global CDMO Market by Service
3.3.1 Global API/Bulk Drugs Market by Value
3.3.2 Global API/Bulk Drugs Market Forecast by Value
3.3.3 Global Drug Product Manufacturing Market by Value
3.3.4 Global Drug Product Manufacturing Market Forecast by Value
3.3.5 Global Packaging Market by Value
3.3.6 Global Packaging Market Forecast by Value
3.4 Global CDMO Market by Product
3.4.1 Global Biologics CDMO Market by Value
3.4.2 Global Biologics CDMO Market Forecast by Value
3.4.3 Global Small Molecule CDMO Market by Value
3.4.4 Global Small Molecule CDMO Market Forecast by Value
3.5 Global CDMO Market by Region

4. Regional CDMO Market Analysis
4.1 North America
4.1.1 North America CDMO Market by Value
4.1.2 North America CDMO Market Forecast by Value
4.2 Europe
4.2.1 Europe CDMO Market by Value
4.2.2 Europe CDMO Market Forecast by Value
4.3 Asia Pacific
4.3.1 Asia Pacific CDMO Market by Value
4.3.2 Asia Pacific CDMO Market Forecast by Value
4.4 Latin America
4.4.1 Latin America CDMO Market by Value
4.4.2 Latin America CDMO Market Forecast by Value
4.5 Middle East & Africa
4.5.1 Middle East & Africa CDMO Market by Value
4.5.2 Middle East & Africa CDMO Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Per Capita Disposable Income
5.1.2 Increasing Global Healthcare Expenditure
5.1.3 Rising Aging Population
5.1.4 Increasing R&D Spending
5.1.5 Growing Number of New Drugs
5.1.6 Rise in Investments and Strategic Collaborations
5.1.7 Growing Demand for Pharmaceutical Products
5.2 Key Trends & Developments
5.2.1 Increasing Demand for Highly Potent API Manufacturing Services
5.2.2 Growing Demand for Quality by Design Services
5.2.3 Growth in Oncology Segment
5.2.4 Growing Demand for Process Development CDMO Services
5.2.5 Lengthy and Costly Drug Development Process
5.3 Challenges
5.3.1 Stringent Government Regulations

6. Competitive Landscape
6.1 Global Market
6.1.1 Key Players - Revenue Comparison
6.1.2 Key Players - Market Cap Comparison

7. Company Profiles
7.1 Catalent, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.2 Recipharm AB
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.3 Evotec SE
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.4 Lonza Group AG
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.5 Biomerieux SA
7.5.1 Business Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.6 Thermo Fisher Scientific Inc.
7.6.1 Business Overview
7.6.2 Financial Overview
7.6.3 Business Strategies

For more information about this report visit https://www.researchandmarkets.com/r/pe6xtv


Contact Data